Your cart:$0.00(0 items) Check yourbonu$
Site search:
Categories list

Generic Daclatasvir - Daklinza, Natdac

Daklinza

Generic Daklinza

Daclatasvir 60mg

Generic Daklinza is an antiviral medicine that precludes hepatitis C virus (HCV) to spread out in your body. It is used to cure genotype 3 chronic hepatitis C in mature patients without cirrhosis. This medicine is taken with another antiviral drug named sofosbuvir.

More info »
$8.93 Buy now!
Natdac

Natdac®

Daclatasvir 60mg

Natdac® is an inhibitor of the viral (hepatitis C virus) protein NS5A, which is used in the replication of hepatitis C virus within the liver cells (hepatocytes) and, thus, prevents the virus from entering infected hepatocytes into the blood. Thanks to this action, it is possible to prevent the spread of the virus in the body. Natdac® (daсlatasvir) is a highly specific direct action agent against hepatitis C virus (HCV) and has no pronounced activity against other RNA and DNA containing viruses, including human immunodeficiency virus (HIV). Natdac®, as an inhibitor of the nonstructural protein 5A (NS5A), a multifunctional protein required for HCV replication, suppresses two stages of the life cycle of the virus-viral RNA replication and virion assembly.

More info »
$8.03 Buy now!
Choose Your language:
Social bookmarks:
Testimonials
Thank you for the complimentary pack of Sildenafil Citrate I'll be sure to put them to good use.
Read more »

Our billing is certified by:

Secure shopping certificates


Special Offer!

Hepatitis C Drugs Market Upsurge Forecast Report 2028 with Latest Industry Developements 2022 - EIN News
Hepatitis C Drugs Market Upsurge Forecast Report 2028 with Latest Industry Developements 2022  EIN News
Safety, Efficacy of Sofosbuvir Plus Daclatasvir in Patients With COVID-19 - Infectious Disease Advisor
Safety, Efficacy of Sofosbuvir Plus Daclatasvir in Patients With COVID-19  Infectious Disease Advisor
Efficacy and safety of sofosbuvir plus daclatasvir or ravidasvir in patients with COVID‐19: A randomized controlled trial - Wiley
Efficacy and safety of sofosbuvir plus daclatasvir or ravidasvir in patients with COVID‐19: A randomized controlled trial  Wiley
Sofosbuvir with Ledipasvir and Daclatasvir: Scientists recommend better alternative to Remdesivir - The New Indian Express
Sofosbuvir with Ledipasvir and Daclatasvir: Scientists recommend better alternative to Remdesivir  The New Indian Express
Sofosbuvir/daclatasvir drugs may be effective coronavirus treatment - EurekAlert
Sofosbuvir/daclatasvir drugs may be effective coronavirus treatment  EurekAlert
Centralux Ltd
bookmark Bookmark this site
Subscribe to the News